Vapers Digest 21st February

Wednesday’s News at a glance:


NNA_Banner_Support_Trans

Global Forum on Nicotine

THR advocates and researchers continue to analyse the fallout from #COP10FCTC, and its implications for millions of users of safer products around the globe. In this special episode of GFN News, Brent Stafford of Regulator Watch asked leading THR experts at the Good COP / Bad COP event in Panama for their response to the events of #COP10FCTC.




Public health groups across the country have found a new enemy in their war on nicotine: smoking cessation products. These so-called health groups are pushing to make life saving products harder to buy and less appealing than cigarettes.

“These are organizations whose goal is the health and well-being of Canadians. They have lost their way. Shouldn’t they be making sure that smoking cessation products are available to adults who smoke and easy for them to purchase?” said Maria Papaioannoy, spokesperson for Rights4Vapers. “We fought to keep vaping accessible. We will fight for all kinds of effective smoking cessation products.”

Financial Analyst: Disposable Vapes Killing Altria’s Cigarette Sales

Jim McDonald, Vaping 360

Analysis published last week by Barclays Research—the investment research arm of the multinational bank—suggests that U.S. tobacco giant Altria Group will fall short of its fiscal year 2024 earnings estimates unless falling cigarette sales can be revived with a crackdown on disposable vapes.

Barclays forecasts Altria’s fiscal year 2024 cigarette shipping volumes to decline by 10 percent, and models a 2 percent decline in EBIT (earnings before interest and taxes, a common measure of profitability).

Vape and modern oral sales are rising,

but combustibles remain king of the North American market

Timothy S. Donahue, Tobacco Reporter

It’s constant but unknown. While the nicotine market remains profitable, it is changing. As more major tobacco companies embrace next-generation products, combustible sales will suffer. The evolving regulatory environment will also continue to play a major factor in the North American nicotine market.

According to Statista, in 2024, revenue in the U.S. nicotine market will reach $107.5 billion. It is projected to experience a compound annual growth rate of 0.62 percent between 2024 and 2028.


Scaremongering’s Forever Effects

Dr. Brad Rodu, Tobacco Truth

With the emergence of nicotine pouches, claims from the 1980s about the health risks of smokeless tobacco (ST) use have reappeared. Nicotine pouches are an important addition to smokers’ options for reducing harm, but it is inappropriate to devalue them by overstating the risks of ST use, such as opining that it causes leukoplakia and periodontal disease.  This is not the case, and I wish to set the record straight.

The Dire Consequences of Australia’s Vape Prohibition

Diane Caruana, Vaping Post

In line with warnings by countless tobacco harm reduction groups and experts, Australia’s strict anti-vaping stance has inadvertently fueled a flourishing illicit market for vaping products, mirroring the failures of 20th-century drug prohibition. In the Western world, Australia stands alone in requiring a nicotine prescription for legal vaping. As expected, this has pushed over 90% of its 1.7 million adult vapers towards the illicit market and led to an estimated 120 million disposable, unregulated vapes being illegally imported from China each year.

Vaping helps smokers quit say researchers

AP Archive, Youtube

The Advocates Voice 2024 Australia and the United Kingdom

CAPHRA Asia Pacific

In this episode we explore the situation in Australia and the evolving situation in the United Kingdom. Draconian “regulations” or De Facto Ban? Language Warning. We let you hear from the people directly impacted.

Rishi Sunak urged to U-turn on UK vape ban over black market fears


Visit Nicotine Science & Policy for more News from around the World

NSP-DG


innco-02

Tagged with: , , , , , , , , , , , , , , , , , , , , , , , , ,
Skip to toolbar